EUVIMEDObjevte EUVIMED
Crossref

Synergistic Activity of Indolicidin and Tigecycline Against Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates

Rami ALtameemi, Abdulameer M Ghareeb, Basim Shamkhi Rahal

Cellular Physiology and Biochemistry · 2025

DOI: 10.33594/000000759 ↗

At a glance

Journal article in Cellular Physiology and Biochemistry, 2025. Written by Rami ALtameemi and 2 co-authors. Institution: Institute of Genetic Engineering and Biotechnology for postgraduate studies, University of Baghdad, Baghdad, Iraq. Major MEDLINE topics: Acinetobacter baumannii, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents, Minocycline.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background/Aims: Acinetobacter baumannii is a ubiquitous opportunistic microorganism associated with high morbidity and mortality Particularly among burn patients and immunocompromised individuals. This study aimed to assess the time-dependent antimicrobial effectiveness of indolicidin in combination with tigecycline against multidrug-resistant (MDR) A. baumannii isolates from patients with wound infections.

Methods

The antimicrobial synergy between indolicidin and tigecycline was evaluated using the checkerboard broth microdilution method And anti-biofilm activity was assessed using the crystal violet assay. Ten isolates resistant to multiple antibiotics were identified and confirmed using the API 20-NE system.

Results

Fractional inhibitory concentration (FIC) values ranged from 0.97 to 250 µg/ml. The results demonstrated that the inhibitory activity of indolicidin and tigecycline was significantly enhanced when combined With FIC values between 0.046 and 0.312 µg/ml. The MIC of indolicidin for isolate A4 decreased from 62.5 to 0.97 µg/ml • While the MIC of tigecycline decreased from 500 to 15.6 µg/ml • Indicating a strong synergistic effect. Additionally The combination therapy led to a 78% reduction in biofilm formation.

Conclusion

This study suggests a novel combination therapy for treating wound infections caused by MDR A. baumannii • Demonstrating significant efficacy in both bacterial inhibition and biofilm reduction.

Subjects

MeSH terms (MEDLINE)

Acinetobacter baumanniiDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsMinocyclineAntimicrobial Cationic PeptidesTigecyclineDrug SynergismMicrobial Sensitivity TestsBiofilmsHumansAcinetobacter Infections

Author keywords

Acinetobacter baumannii; Multidrug-resistant (MDR) bacteria; Indolicidin; Tigec…

Substances

TigecyclineAnti-Bacterial AgentsMinocyclineindolicidinAntimicrobial Cationic Peptides

Authors and institutions

  • Institute of Genetic Engineering and Biotechnology for postgraduate studies, University of Baghdad, Baghdad, Iraq.

Cite

APA

ALtameemi, R., Ghareeb, A. M., & Rahal, B. S. (2025). Synergistic Activity of Indolicidin and Tigecycline Against Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates. Cellular Physiology and Biochemistry. https://doi.org/10.33594/000000759

Vancouver

ALtameemi R, Ghareeb AM, Rahal BS. Synergistic Activity of Indolicidin and Tigecycline Against Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates. Cellular Physiology and Biochemistry. 2025. doi:10.33594/000000759

BibTeX
@article{ALtameemi2025,
  author = {ALtameemi, Rami and Ghareeb, Abdulameer M and Rahal, Basim Shamkhi},
  title = {Synergistic Activity of Indolicidin and Tigecycline Against Multidrug-Resistant Acinetobacter Baumannii Clinical Isolates},
  journal = {Cellular Physiology and Biochemistry},
  year = {2025},
  doi = {10.33594/000000759}
}
Start for free →